Please use this identifier to cite or link to this item:
Title: Topical azithromycin or ofloxacin for endophthalmitis prophylaxis after intravitreal injection.
Author: Romero-Aroca, Pedro
Sararols, Laura
Arias Barquet, Lluís
Casaroli Marano, Ricardo Pedro
Bassaganyas, Francisca
Keywords: Antibiòtics
Infeccions oculars
Cirurgia ocular
Medicina preventiva
Eye infections
Eye surgery
Preventive medicine
Issue Date: 9-Oct-2012
Publisher: Dove Medical Press
Abstract: Background: The number of patients who have undergone intravitreal injections has increased enormously in recent years, but a consensus is still lacking on prophylaxis for endophthalmitis. The aim of this prospective, observational study was to evaluate the prophylactic effect of azithromycin eye drops versus ofloxacin eye drops. Methods: The study was conducted in five hospitals in Spain and included all patients under going intravitreal injections of triamcinolone, bevacizumab, ranibizumab, or pegaptanib over one year. Patients received azithromycin 15 mg/g eye drops (twice daily on the day prior to injection and for another 2 days) or ofloxacin 3 mg/g eye drops (every 6 hours on the day prior to injection and for another 7 days). Results: In the azithromycin group, there were 4045 injections in 972 eyes of 701 patients. In the ofloxacin group, there were 4151 injections in 944 eyes of 682 patients. There were two cases of endophthalmitis (0.049%) in the azithromycin group and five (0.12%) in the ofloxacin group. The odds ratio of presenting with endophthalmitis in the ofloxacin group compared with the azithromycin group was 2.37 (95% confidence interval [CI] 1.32-3.72, P ,0.001). There were two cases of noninfectious uveitis after triamcinolone injection in the azithromycin group (0.049%) and two (0.048%) in the ofloxacin group; no significant differences were observed (odds ratio 0.902, 95% CI 0.622-1.407, P= 0.407). Conjunctival hyperemia was observed in 12 cases in the azithromycin group and none in the ofloxacin group. Conclusion: The risk of endophthalmitis was significantly greater with ofloxacin than with azithromycin. These findings provide a valuable addition to the ever-increasing pool of infor - mation on endophthalmitis prophylaxis after intravitreal injection, although further large-scale studies are required to provide definitive conclusions.
Note: Reproducció del document publicat a:
It is part of: Clinical Ophthalmology, 2012, vol. 6, p. 1595-1599
Related resource:
ISSN: 1177-5467
Appears in Collections:Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)

Files in This Item:
File Description SizeFormat 
626939.pdf163.93 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons